CAS 2230198-02-2 appears in our catalog under these names: PF-06882961/ 99.54% (existing batch purity), PF–06882961, Danuglipron 98%, Danuglipron, 99.85%. Offered by: TargetMol, GLPBio, Ambeed, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso), 10g.
Danuglipron is a benzimidazolecarboxylic acid that is 1H-benzimidazole substituted by (2S)-oxetan-2-ylmethyl, (4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl, and carboxy groups at positions 1, 2, and 6, respectively. It is a glucagon-like peptide-1 receptor agonist in development for the treatment of type 2 diabetes and obesity. It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist and an anti-obesity agent. It is a nitrile, a member of piperidines, a member of pyridines, an aromatic ether, a benzimidazolecarboxylic acid, a member of oxetanes and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C31H30FN5O4 |
|---|---|
| Molecular weight | 555.6 g/mol |
| IUPAC name | 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid |
| InChIKey | HYBAKUMPISVZQP-DEOSSOPVSA-N |
| SMILES | C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F |
Computed by PubChem (NCBI)